Separate compounded and brand-name paths
Zepbound is an FDA-approved tirzepatide product. Compounded tirzepatide is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality. Compare prices within the same path before deciding which option to discuss with a clinician.
Even within the compounded category, note whether the quote is for an injection, an oral formulation, or an individualized low-dose program. A $90 starter vial and a $239 bundled annual plan do not necessarily represent the same dose, care model, or commitment.
Watch for dose-linked price changes
Tirzepatide programs can price by dose. The opening number may correspond to the lowest dose, while later amounts can rise substantially. Ask whether the price is flat at every dose, locked for existing patients, or recalculated as the prescription changes.
If a site publishes a range, budget from the range rather than the minimum. If it publishes only “from,” treat that as an entry point until you receive a written quote for the dose a clinician actually prescribes.
Calculate the real commitment
Some low monthly equivalents require a six- or twelve-month purchase. Multiply the monthly figure by the commitment and identify what is due at checkout. A flexible month-to-month program may cost more per month but expose less cash if treatment is changed or stopped.
Cancellation terms matter because prescription and pharmacy fulfillment can begin quickly. Review the refund policy before completing payment, especially for prepaid medication programs.
Verify the care layer
Ask who reviews the intake, how follow-up questions are handled, whether dose changes require another visit, whether shipping is included, and what happens if the medication is unavailable in your state. The lowest medication price can lose its advantage if clinical care or fulfillment creates separate charges.
Where the numbers come from
We use publicly accessible provider-owned pricing pages and preserve the condition attached to each figure. See the full methodology, source list, and current provider comparison.